NDC 51662-1418 – Nalbuphine Hci
Nalbuphine Hydrochloride 20 mg/mL · Injection, Solution · Intramuscular, Intravenous, Subcutaneous
Product NDC51662-1418
Product details
- Brand name
- Nalbuphine Hci
- Generic name
- Nalbuphine Hci
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous, Subcutaneous
- Marketing category
- ANDA · ANDA070918
- Marketed since
- October 29, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Opioid Agonist/Antagonist
Active ingredients
- Nalbuphine Hydrochloride 20 mg/mL
Uses, dosage, side effects and warnings for Nalbuphine Hci →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 51662-1418-1 | 1 VIAL, MULTI-DOSE in 1 CARTON (51662-1418-1) / 10 mL in 1 VIAL, MULTI-DOSE | Oct 29, 2019 |
Other Nalbuphine Hci products
- 51662-1420 Nalbuphine Hydrochloride 10 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst